173 related articles for article (PubMed ID: 36851183)
1. The Development of Surface-Modified Liposomes as an Intranasal Delivery System for Group A Streptococcus Vaccines.
Yang J; Boer JC; Khongkow M; Phunpee S; Khalil ZG; Bashiri S; Deceneux C; Goodchild G; Hussein WM; Capon RJ; Ruktanonchai U; Plebanski M; Toth I; Skwarczynski M
Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851183
[TBL] [Abstract][Full Text] [Related]
2. Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus.
Nevagi RJ; Khalil ZG; Hussein WM; Powell J; Batzloff MR; Capon RJ; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2018 Oct; 80():278-287. PubMed ID: 30266637
[TBL] [Abstract][Full Text] [Related]
3. Cell-Penetrating Peptides-Based Liposomal Delivery System Enhanced Immunogenicity of Peptide-Based Vaccine against Group A Streptococcus.
Yang J; Firdaus F; Azuar A; Khalil ZG; Marasini N; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccines (Basel); 2021 May; 9(5):. PubMed ID: 34066099
[TBL] [Abstract][Full Text] [Related]
4. Activity Relationship of Poly(ethylenimine)-Based Liposomes as Group A
Jin S; Zhang J; Nahar UJ; Huang W; Alharbi NA; Shalash AO; Koirala P; Yang J; Kiong JJE; Khalil ZG; Capon RJ; Stephenson RJ; Skwarczynski M; Toth I; Hussein WM
ACS Infect Dis; 2023 Aug; 9(8):1570-1581. PubMed ID: 37489053
[TBL] [Abstract][Full Text] [Related]
5. Polyethylenimine: An Intranasal Adjuvant for Liposomal Peptide-Based Subunit Vaccine against Group A
Dai CC; Yang J; Hussein WM; Zhao L; Wang X; Khalil ZG; Capon RJ; Toth I; Stephenson RJ
ACS Infect Dis; 2020 Sep; 6(9):2502-2512. PubMed ID: 32786276
[TBL] [Abstract][Full Text] [Related]
6. Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery.
Marasini N; Giddam AK; Khalil ZG; Hussein WM; Capon RJ; Batzloff MR; Good MF; Toth I; Skwarczynski M
Nanomedicine (Lond); 2016 Dec; 11(24):3223-3235. PubMed ID: 27830630
[TBL] [Abstract][Full Text] [Related]
7. Highly Immunogenic Trimethyl Chitosan-based Delivery System for Intranasal Lipopeptide Vaccines against Group A Streptococcus.
Marasini N; Ghaffar KA; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Curr Drug Deliv; 2017; 14(5):701-708. PubMed ID: 27440071
[TBL] [Abstract][Full Text] [Related]
8. Poly(hydrophobic Amino Acids) and Liposomes for Delivery of Vaccine against Group A Streptococcus.
Azuar A; Madge HYR; Boer JC; Gonzalez Cruz JL; Wang J; Khalil ZG; Deceneux C; Goodchild G; Yang J; Koirala P; Hussein WM; Capon RJ; Plebanski M; Toth I; Skwarczynski M
Vaccines (Basel); 2022 Jul; 10(8):. PubMed ID: 36016100
[TBL] [Abstract][Full Text] [Related]
9. Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus.
Ghaffar KA; Marasini N; Giddam AK; Batzloff MR; Good MF; Skwarczynski M; Toth I
Acta Biomater; 2016 Sep; 41():161-8. PubMed ID: 27063491
[TBL] [Abstract][Full Text] [Related]
10. Development of Polyelectrolyte Complexes for the Delivery of Peptide-Based Subunit Vaccines against Group A
Zhao L; Jin W; Cruz JG; Marasini N; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Nanomaterials (Basel); 2020 Apr; 10(5):. PubMed ID: 32357402
[TBL] [Abstract][Full Text] [Related]
11. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship of group A streptococcus lipopeptide vaccine candidates in trimethyl chitosan-based self-adjuvanting delivery system.
Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
Eur J Med Chem; 2019 Oct; 179():100-108. PubMed ID: 31247372
[TBL] [Abstract][Full Text] [Related]
13. Enhanced Immune Responses to Mucosa by Functionalized Chitosan-Based Composite Nanoparticles as a Vaccine Adjuvant for Intranasal Delivery.
Lin Y; Sun B; Jin Z; Zhao K
ACS Appl Mater Interfaces; 2022 Nov; 14(47):52691-52701. PubMed ID: 36382954
[TBL] [Abstract][Full Text] [Related]
14. A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus: Lipidation and polyelectrolyte complexes.
Zhao L; Yang J; Nahar UJ; Khalil ZG; Capon RJ; Hussein WM; Skwarczynski M; Toth I
Bioorg Med Chem; 2020 Dec; 28(24):115823. PubMed ID: 33120079
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled monovalent lipidated mannose ligand as a standalone nanoadjuvant.
Nahar UJ; Wang J; Shalash AO; Lu L; Islam MT; Alharbi N; Koirala P; Khalil ZG; Capon RJ; Hussein WM; Toth I; Skwarczynski M
Vaccine; 2024 Jun; ():. PubMed ID: 38897890
[TBL] [Abstract][Full Text] [Related]
16. A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine.
Svindland SC; Pedersen GK; Pathirana RD; Bredholt G; Nøstbakken JK; Jul-Larsen Å; Guzmán CA; Montomoli E; Lapini G; Piccirella S; Jabbal-Gill I; Hinchcliffe M; Cox RJ
Influenza Other Respir Viruses; 2013 Nov; 7(6):1181-93. PubMed ID: 23170900
[TBL] [Abstract][Full Text] [Related]
17. New modular platform based on multi-adjuvanted amphiphilic chitosan nanoparticles for efficient lipopeptide vaccine delivery against group A streptococcus.
Norpi ASM; Nordin ML; Ahmad N; Katas H; Fuaad AAA; Sukri A; Marasini N; Azmi F
Asian J Pharm Sci; 2022 May; 17(3):435-446. PubMed ID: 35782331
[TBL] [Abstract][Full Text] [Related]
18. Self-assembly of trimethyl chitosan and poly(anionic amino acid)-peptide antigen conjugate to produce a potent self-adjuvanting nanovaccine delivery system.
Nevagi RJ; Dai W; Khalil ZG; Hussein WM; Capon RJ; Skwarczynski M; Toth I
Bioorg Med Chem; 2019 Jul; 27(14):3082-3088. PubMed ID: 31176567
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with O-2'-Hydroxypropyl trimethyl ammonium chloride chitosan nanoparticles loaded with Newcastle disease virus DNA vaccine enhances mucosal immune response in chickens.
Zhao K; Sun B; Shi C; Sun Y; Jin Z; Hu G
J Nanobiotechnology; 2021 Aug; 19(1):240. PubMed ID: 34380522
[TBL] [Abstract][Full Text] [Related]
20. Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity.
Henderson A; Propst K; Kedl R; Dow S
Vaccine; 2011 Jul; 29(32):5304-12. PubMed ID: 21600950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
